Business Context and Reporting Period
This Form 8-K Current Report was filed by Neuronetics, Inc. (STIM) on April 4, 2023, covering events occurring on March 29, 2023, and March 31, 2023. The filing details the entry into material definitive agreements regarding debt financing and the conversion of accounts receivable into a secured promissory note.
Key Financial Metrics and Agreements
Solar Facility Amendment (March 29, 2023)
- Agreement: Fourth Amendment to Loan and Security Agreement with SLR Investment Corp. (Solar Capital Ltd.) and lenders.
- Facility Structure: Total capacity of $60.0 million across three tranches: Term A ($35.0 million, fully drawn), Term B ($2.5 million), and uncommitted Term C ($22.5 million).
- New Borrowing: $2.5 million drawn under the Term B Loan on March 29, 2023.
- Maturity: Extended to March 29, 2028 (previously February 28, 2025 for Term A).
- Interest Rate: Floating rate equal to the greater of 3.95% or Daily Simple SOFR + 5.65%.
- Repayment Terms: Interest-only payments required until March 1, 2026; principal and interest monthly thereafter.
- Fees:
- Final payment fee: 4.95% of funded principal upon prepayment, acceleration, or maturity.
- Prepayment fees: 3% (within 1 year), 2% (years 1-2), or 1% (after year 2) of prepaid principal.
- Exit fees: Up to 2.00% of funded principal triggered by liquidation, change of control, or revenue milestones ($100M or $125M trailing twelve-month net product revenue).
Greenbrook Promissory Note (March 31, 2023)
- Counterparties: TMS Neurohealth Centers Inc. (Maker) and Greenbrook TMS Inc. (Guarantors).
- Principal Amount: $6.0 million, converting an outstanding account balance of approximately $5.9 million for TMS devices and treatment sessions.
- Maturity: March 31, 2027.
- Interest Rate: Daily Simple SOFR + 7.65% per annum.
- Repayment Terms: Interest payable starting July 1, 2023; principal payable in 45 equal monthly installments starting July 1, 2023.
- Default Provisions: In the event of default, the Maker must issue common share purchase warrants equal to 200% of the delinquent amount (plus accrued interest/fees) divided by an exercise price at a 20% discount to the 30-day VWAP.
- Security: Secured by substantially all assets of the Maker and Guarantors; ranks pari passu with the Maker's senior lender (Madryn Fund Administration, LLC).
Material Changes Versus Prior Period
The filing does not provide comparative financial statements or revenue data for the prior period. The material changes are structural:
- Debt Maturity Extension: The maturity date for the Term A Loan was extended by approximately three years (from Feb 2025 to March 2028).
- Repayment Schedule Adjustment: The interest-only period for the Solar Facility was extended from March 1, 2023, to March 1, 2026.
- Balance Sheet Conversion: Approximately $5.9 million in accounts receivable was converted into a long-term secured note receivable.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, revenue outlook, or management commentary regarding future performance. However, it outlines specific financial risks and contingencies:
- Revenue Milestone Contingencies: The Company faces potential exit fee obligations (1.00% to 2.00% of funded principal) if it achieves $100 million or $125 million in trailing twelve-month net product revenue.
- Change of Control/Liquidation: A 2.00% exit fee is triggered upon liquidation, dissolution, or a change of control transaction.
- Equity Dilution Risk: Default on the Greenbrook Promissory Note could result in the issuance of warrants representing a significant equity stake (200% of delinquent amount) at a discounted price.
- Prepayment Penalties: Significant fees apply to early repayment of the Solar Facility, ranging from 1% to 3% depending on the timing.
Investor Verification Checklist
- Verify the exact amount of the "Term A Loan" drawn prior to this amendment to calculate total outstanding debt under the Solar Facility.
- Confirm the current trailing twelve-month net product revenue to assess the proximity to the $100M and $125M exit fee triggers.
- Review the creditworthiness of TMS Neurohealth Centers Inc. and Greenbrook TMS Inc. regarding the $6.0 million secured note.
- Monitor the Daily Simple SOFR rate to estimate future interest expense on both the Solar Facility and the Greenbrook Note.
- Check for any subsequent filings regarding the uncommitted $22.5 million Term C Facility under the Solar agreement.